pubmed.ncbi.nlm.nih.gov

Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas - PubMed

Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas

Jessica Costa-Guda et al. J Clin Endocrinol Metab. 2011 Apr.

Abstract

Context: Typical nonfamilial (sporadic) parathyroid adenomas are common endocrine tumors for which no predisposing germline DNA variants and only a few clonally altered genes that drive parathyroid tumorigenesis have been identified. CDKN1B, encoding cyclin-dependent kinase inhibitor p27(kip1), has recently been implicated in a multiple endocrine tumor phenotype in rats and, rarely, in a human familial MEN1 (multiple endocrine neoplasia type 1)-like disorder.

Objective: We sought to determine whether mutation of CDKN1B might contribute to the development of common sporadic parathyroid adenomas.

Patients and design: We sequenced the CDKN1B gene in 86 parathyroid adenomas from patients with typical, sporadic presentations of primary hyperparathyroidism. Identified alterations were categorized as somatic or germline, and their functional consequences were examined.

Results: CDKN1B sequence abnormalities were identified in four parathyroid adenomas. Acquired biallelic alteration of CDKN1B, resulting from somatic mutation plus loss of heterozygosity, was detected in one tumor. Germline origin was documented in two cases despite nonfamilial presentations. None of the observed alterations were found in 240 CDKN1B alleles from normal individuals, nor among more than 2,000 previously reported alleles. Most identified variants reduced p27(kip1) protein levels or altered in vitro stability.

Conclusions: In typical, sporadic parathyroid adenomas, CDKN1B mutation can be somatic and clonal, indicative of a directly conferred selective advantage in parathyroid tumorigenesis. Additionally, the identification of germline CDKN1B variants in patients with sporadic presentations provides evidence for CDKN1B as a susceptibility gene in the development of typical parathyroid adenomas.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.

In vivo and in vitro analyses of CDKN1B mutants. A, Twenty-five base pair somatic deletion mutation identified in patient 4 (c.582del25). The top electropherogram shows the germline sequence, while the bottom electropherogram shows the tumor sequence. Sequence deleted in the tumor is indicated by a bar above the germline sequence, and the position of the mutation in the tumor sequence is indicated by an asterisk (*) and a red bar between the nucleotides flanking the deletion. The presence of clear DNA sequence downstream of the deletion, unaccompanied by overlying sequence in the normal (or other) reading frame, indicates the singular presence of the mutant allele, consistent with LOH. LOH of CDKN1B and the surrounding region in this case was also observed in comparative genomic hybridization and single nucleotide polymorphism array analyses (Supplemental Refs. 1 and 2). B, Schematic of the CDKN1B transcripts obtained by RT-PCR. Numbers 1 to 4 indicate the bands in the gel in C. Sequences of bands 1 and 2 (corresponding to lane 5 in C) were consistent with normal splicing (exon 1 to exon 2 to exon 3), the larger band 1 (350 bp) representing full-length exon 2 (line 1), likely from rare admixed normal nonparathyroid cells, and the smaller band 2 (325 bp) being exon 2 with a 25-bp deletion (line 2). Sequence analysis of band 3 (212 bp) revealed a novel isoform of p27 mRNA resulting from splicing of exon 1 directly to exon 3, skipping exon 2 (line 3). A third novel isoform of p27 was detected, corresponding to band 4 (292 bp) in C. Sequence analysis of this band was consistent with splicing of exon 1 to exon 2 with continuation into intron 2 rather than splicing to exon 3 (line 4). C, RT-PCR for p27 in normal control from placenta (lanes 2 and 3) and tumor 4 (lanes 4, 5, and 6). Forward and reverse primers used for reaction are listed above each lane. The presence of p27 mRNA was confirmed in control (lane 2) by using a forward primer in exon 1 and a reverse primer in exon 3 and in tumor (lane 4) by using a forward primer in exon 1 and a reverse primer in exon 2. Using a forward primer in exon 1 and a reverse primer in exon 3, three distinct bands were detected in the tumor sample (lane 5), while only one was present in the control (lane 2). An additional novel isoform of p27 was detected in tumor 4 using a primer in exon 1 and a primer in intron 2 (lane 6), which was absent in the control (lane 3); because the primer combination also spanned intron 1, this band was distinguishable from genomic DNA based on size. Samples included in this study were grossly dissected before RNA extraction; as such, the presence of wt p27 message in this sample was likely attributable to contamination by normal stroma, confirmed by positive p27 staining of adjacent endothelial cells. Despite the presence of mRNA, no normal p27 protein was detected in tumor cells by IHC (D, right). D, Tumor tissues from two individuals were available for immunohistochemical analysis. Left, p27 immunohistochemical staining of the parathyroid adenoma of patient 1 (bearing the c.25G>A mutation). Less than 20% of tumor cells (×200) demonstrate expression of p27. Right, p27 staining of the parathyroid adenoma of patient 4 (bearing the c.582del25 mutation) shows no p27 immunoreactivity in the tumor cells (×200), which can be better appreciated in the inset (×400). Normal endothelial cells strongly positive for p27 serve as internal control (arrows). E, Turnover of p27-wt and of p27-G9R and p27-P133T proteins was measured in cells after CHX treatment with and without the proteasome inhibitor epoxomycin. Immunoblotting was done with the indicated antibodies. p27-wt and p27-P133T have a half-life of approximately 10 h in GH3 cells; epoxomycin partially blocks p27-wt and p27-P133T degradation but not p27-G9R degradation (lower section). Thus, the instability of p27-G9R appears to be attributable in large part to proteasome-independent mechanisms. The histograms above show the band intensities normalized against α-tubulin loading controls.

Similar articles

Cited by

References

    1. Hendy GN, Arnold A. 2008. Molecular basis of PTH overexpression. In: Bilezikian JP, Raisz LG, Martin TJ. eds. Principles of bone biology. San Diego, CA: Academic Press; 1311–1326
    1. McClellan J, King MC. 2010. Genetic heterogeneity in human disease. Cell 141:210–217 - PubMed
    1. Bodmer W, Bonilla C. 2008. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40:695–701 - PMC - PubMed
    1. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Höfler H, Fend F, Graw J, Atkinson MJ. 2006. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 103:15558–15563 - PMC - PubMed
    1. Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, Mäkinen MJ, Tuppurainen K, Paschke R, Gimm O, Koch CA, Gündogdu S, Lucassen A, Tischkowitz M, Izatt L, Aylwin S, Bano G, Hodgson S, De Menis E, Launonen V, Vahteristo P, Aaltonen LA. 2007. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 92:3321–3325 - PubMed

Publication types

MeSH terms

Substances